Pre-cum-Mains GS Foundation Program for UPSC 2026 | Starting from 5th Dec. 2024 Click Here for more information
Source: The post is based on the article “CDC concerned about drug-resistant bacteria strain allegedly linked to eye-drops imported from India” published in The Hindu on 4th April 2023
What is the News?
The Centers for Disease Control(CDC) has warned people to stop using “artificial tear” eye drops sold by EzriCare.
What are EzriCare Eye Drops?
The eye-drops were manufactured by Chennai-based Global Pharma Healthcare and distributed in the U.S. market by EzriCare and Delsam Pharma.
CDC has found an “extensively” antibiotic-resistant Pseudomonas aeruginosa bacteria in multiple open containers of eye drops.
Hence, CDC has cautioned that patients should stop using the eye-drops pending additional Information and guidance.
Note: Recently, World Health Organisation(WHO) issued two medical product alerts on cough syrups manufactured in India which were exported to Gambia and Uzbekistan.
How are the medicines exported from India?
Ministry of Chemicals and Fertilizers in its response to a question on the export of “substandard medicines” said that manufacturers were required to obtain a license for manufacturing of drugs for export from the concerned State Licensing Authority (SLA) under the provisions of the Drugs and Cosmetics Act,1940 and the rules made thereunder.
Further, all manufacturers were required to meet the requirements of the importing country.
